Neuroserpin is a member of the serine protease inhibitor or serpin superfamily of proteins. It is secreted by neurones and plays an important role in the regulation of tissue plasminogen activator at the synapse. Point mutations in the neuroserpin gene cause the autosomal dominant dementia familial encephalopathy with neuroserpin inclusion bodies or FENIB. This is one of a group of disorders caused by mutations in the serpins that are collectively known as the serpinopathies. Others include alpha(1)-antitrypsin deficiency and deficiency of C1 inhibitor, antithrombin and alpha(1)-antichymotrypsin. The serpinopathies are characterised by delays in protein folding and the retention of ordered polymers of the mutant serpin within the cell of synthesis. The clinical phenotype results from either a toxic gain of function from the inclusions or a loss of function, as there is insufficient protease inhibitor to regulate important proteolytic cascades. We describe here the methods required to characterise the polymerisation of neuroserpin and draw parallels with the polymerisation of alpha(1)-antitrypsin. It is important to recognise that the conditions in which experiments are performed will have a major effect on the findings. For example, incubation of monomeric serpins with guanidine or urea will produce polymers that are not found in vivo. The characterisation of the pathological polymers requires heating of the folded protein or alternatively the assessment of ordered polymers from cell and animal models of disease or from the tissues of humans who carry the mutation. (C) 2010 Elsevier Inc. All rights reserved.

Characterisation of serpin polymers in vitro and in vivo / Didier, Belorgey; James A., Irving; Ugo I., Ekeowa; Joanna, Freeke; Benoit D., Roussel; MIRANDA BANOS, MARIA ELENA; Juan, Perez; Stefan J., Marciniak; Damian C., Crowther; C. H., Michel; David A., Lomas. - In: METHODS. - ISSN 1046-2023. - 53:3(2011), pp. 255-266. [10.1016/j.ymeth.2010.11.008]

Characterisation of serpin polymers in vitro and in vivo

MIRANDA BANOS, MARIA ELENA;
2011

Abstract

Neuroserpin is a member of the serine protease inhibitor or serpin superfamily of proteins. It is secreted by neurones and plays an important role in the regulation of tissue plasminogen activator at the synapse. Point mutations in the neuroserpin gene cause the autosomal dominant dementia familial encephalopathy with neuroserpin inclusion bodies or FENIB. This is one of a group of disorders caused by mutations in the serpins that are collectively known as the serpinopathies. Others include alpha(1)-antitrypsin deficiency and deficiency of C1 inhibitor, antithrombin and alpha(1)-antichymotrypsin. The serpinopathies are characterised by delays in protein folding and the retention of ordered polymers of the mutant serpin within the cell of synthesis. The clinical phenotype results from either a toxic gain of function from the inclusions or a loss of function, as there is insufficient protease inhibitor to regulate important proteolytic cascades. We describe here the methods required to characterise the polymerisation of neuroserpin and draw parallels with the polymerisation of alpha(1)-antitrypsin. It is important to recognise that the conditions in which experiments are performed will have a major effect on the findings. For example, incubation of monomeric serpins with guanidine or urea will produce polymers that are not found in vivo. The characterisation of the pathological polymers requires heating of the folded protein or alternatively the assessment of ordered polymers from cell and animal models of disease or from the tissues of humans who carry the mutation. (C) 2010 Elsevier Inc. All rights reserved.
alpha-1 antitrypsin; conformational diseases; fenib; neuroserpin; serpin
01 Pubblicazione su rivista::01a Articolo in rivista
Characterisation of serpin polymers in vitro and in vivo / Didier, Belorgey; James A., Irving; Ugo I., Ekeowa; Joanna, Freeke; Benoit D., Roussel; MIRANDA BANOS, MARIA ELENA; Juan, Perez; Stefan J., Marciniak; Damian C., Crowther; C. H., Michel; David A., Lomas. - In: METHODS. - ISSN 1046-2023. - 53:3(2011), pp. 255-266. [10.1016/j.ymeth.2010.11.008]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/142281
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 19
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 33
social impact